X
Edition:
United States

  • Business
    • Business Home
    • Legal
    • Deals
    • Aerospace & Defense
    • Finance
    • Autos
    • Reuters Summits
  • Markets
    • Markets Home
    • U.S. Markets
    • European Markets
    • Asian Markets
    • Global Market Data
    • Indices
    • Stocks
    • Bonds
    • Currencies
    • Comm & Energy
    • Futures
    • Funds
    • Earnings
    • Dividends
  • World
    • World Home
    • U.S.
    • Special Reports
    • Reuters Investigates
    • Euro Zone
    • Middle East
    • China
    • Japan
    • Mexico
    • Brazil
    • Africa
    • Russia
    • India
  • Politics
    • Politics Home
    • Election 2016
    • Polling Explorer
    • Just In
    • What Voters Want
    • Supreme Court
  • Tech
    • Technology Home
    • Science
    • Top 100 Global Innovators
    • Environment
    • Innovation
  • Commentary
    • Commentary Home
    • Podcasts
  • Breakingviews
    • Breakingviews Home
    • Breakingviews Video
  • Money
    • Money Home
    • Retirement
    • Lipper Awards
    • Analyst Research
    • Stock Screener
    • Fund Screener
  • Rio 2016
  • Pictures
    • Pictures Home
    • The Wider Image
    • Photographers
    • Focus 360
  • Video
Embryonic-like cells repair damaged mouse hearts
  • Africa
    América Latina
  • عربي
    Argentina
  • Brasil
    Canada
  • 中国
    Deutschland
  • España
    France
  • India
    Italia
  • 日本
    México
  • РОССИЯ
    United Kingdom
  • United States
Science News | Mon Jul 20, 2009 4:31pm EDT

Embryonic-like cells repair damaged mouse hearts

By Julie Steenhuysen | CHICAGO

CHICAGO Ordinary cells reprogrammed to act like embryonic stem cells can help repair damaged heart tissue in mice, researchers reported on Monday in a study that shows a potential practical use for the experimental cells.

When injected into mice whose hearts had been damaged by a heart attack, the new cells helped improve both the structure and function of the heart. Eventually the hope would be to patch up seriously ill heart patients using their own cells.

"It was obvious to the observer which animals had been treated and which ones hadn't," said Dr Timothy Nelson of the Mayo Clinic in Rochester, Minnesota, whose study appears in the journal Circulation.

The team used a promising new type of embryonic-like stem cell called an induced pluripotent stem cell, or iPS cell, made from ordinary cells. Many teams are using this new technology to look for ways to repair the body, a fast-growing field of research known as regenerative medicine.

Nelson and colleagues tested the technology as a way to regenerate heart muscle damaged by a heart attack.

"We're taking advantage of a diseased tissue environment that is sending out a distress signal that is asking the tissue to repair itself," Nelson said.

"When we put these iPS cells in, they are able to respond."

Like embryonic stem cells, induced pluripotent stem cells have the ability to form any kind of cell in the body. Because they come from adult tissue, their use is less controversial than embryonic stem cells, which come from days-old embryos.

There are several ways to make iPS cells, but Nelson's team used a method in which a virus is used to transplant genes that turn back the clock on the cells.

For Nelson, the point was not making the cells, but seeing whether they could make any difference in damaged heart tissue.

'WOW FACTOR'

Instead of coaxing the iPS cells into a specific type of heart tissue, they used the iPS cells in their most embryonic-like state.

Nelson said two weeks after they had transplanted the cells, they started making different types of heart tissue, including heart muscle, blood vessels and the cells that line blood vessels.

"They were able to respond to this damaged environment and spontaneously give rise to the appropriate tissues and create new tissues within that diseased heart," he said. "That is a key wow factor of this paper."

Nelson said heart cells continued to grow for four weeks, and the mice that got the iPS cells got better.

Both the structure and the function of their hearts improved compared to animals injected with cells that form scar tissue, he said.

The treated animals were able to move better, and an ultrasound found significant improvement in the ability of the heart to pump blood.

Nelson said the finding shows promise for human treatments. IPS cells could in theory be made using a patient's own skin, allowing grow-your-own transplants with no risk of rejection.

Currently, no iPS cells are being used in people because scientists are still working on safe ways to make them, and several teams have made progress.

Nelson said it may take several years, but he thinks the technology could be used to help people in need of heart transplants.

(Editing by Maggie Fox and Eric Beech)

Trending Stories

    Editor's Pick

    LIVE: Election 2016

    Sponsored Topics

    Next In Science News

    Piltdown breakdown: new details about a famed scientific hoax

    WASHINGTON Researchers applying modern forensic techniques to a century-old puzzle have laid bare intriguing new details about one of the most notorious scientific hoaxes on record, the so-called Piltdown Man, and are confident in the culprit's identity.

    What3words keeps Olympics visitors on track in Rio

    An innovative addressing system that assigns every patch of earth in the world an easy to remember three-word address is being used to help visitors get around at the Olympics in Rio de Jeneiro. Some 500,000 foreigners are expected to pass through the city during the Games that run until August 21.

    Paralysis partly reversed using brain-machine interface training

    Paraplegic patients recovered partial control and feeling in their limbs after training to use a variety of brain-machine interface technologies, according to new research published on Thursday in the journal "Scientific Reports."

    MORE FROM REUTERS

    From Around the Web By Taboola

    Sponsored Content By Dianomi

    X
    Follow Reuters:
    • Follow Us On Twitter
    • Follow Us On Facebook
    • Follow Us On RSS
    • Follow Us On Instagram
    • Follow Us On YouTube
    • Follow Us On LinkedIn
    Subscribe: Feeds | Newsletters | Podcasts | Apps
    Reuters News Agency | Brand Attribution Guidelines | Delivery Options

    Reuters is the news and media division of Thomson Reuters. Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Learn more about Thomson Reuters products:

    Eikon
    Information, analytics and exclusive news on financial markets - delivered in an intuitive desktop and mobile interface
    Elektron
    Everything you need to empower your workflow and enhance your enterprise data management
    World-Check
    Screen for heightened risk individual and entities globally to help uncover hidden risks in business relationships and human networks
    Westlaw
    Build the strongest argument relying on authoritative content, attorney-editor expertise, and industry defining technology
    ONESOURCE
    The most comprehensive solution to manage all your complex and ever-expanding tax and compliance needs
    CHECKPOINT
    The industry leader for online information for tax, accounting and finance professionals

    All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.

    • Site Feedback
    • Corrections
    • Advertise With Us
    • Advertising Guidelines
    • AdChoices
    • Terms of Use
    • Privacy Policy